Gene · 10642
Papers3,895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,895
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sex-specific perturbations of neuronal development caused by mutations in the autism risk gene DDX3X. | Nat Commun | 2025 | 40374608 | PubTator, text mining | PubMed |
| BRD4 regulates m6A of ESPL1 mRNA via interaction with ALKBH5 to modulate breast cancer progression. | Acta Pharm Sin B | 2025 | 40370540 | PubTator, text mining | PubMed |
| Dynamic role of long noncoding RNA in liver diseases: pathogenesis and diagnostic aspects. | Clin Exp Med | 2025 | 40369230 | PubTator, text mining | PubMed |
| FTO alleviated the diabetic nephropathy progression by regulating the N6-methyladenosine levels of DACT1. | Open Life Sci | 2025 | 40356725 | PubTator, text mining | PubMed |
| The RNA-Binding Proteins MCPIP2 and IGF2BP1 Competitively Modulate Breast Tumor Angiogenesis by Antagonizing VEGFA mRNA Stability and Expression. | FASEB J | 2025 | 40354028 | PubTator, text mining | PubMed |
| Genetic variants in m6A regulator genes confer susceptibility and progression of HCC in a Northern Chinese population. | Discov Oncol | 2025 | 40232555 | PubTator, text mining | PubMed |
| β-adrenergic receptor inhibits heart regeneration by downregulating Yap m6A modification. | Cell Death Dis | 2025 | 40229267 | PubTator, text mining | PubMed |
| The induction effect of hydroxyurea and metformin on fetal globin in the K562 cell line. | Mol Med | 2025 | 40200166 | PubTator, text mining | PubMed |
| METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14. | Int J Biol Macromol | 2025 | 40194572 | PubTator, text mining | PubMed |
| Interaction of PHGDH with IGF2BP1 facilitates m6A-dependent stabilization of TCF7L2 mRNA to confer multidrug resistance in gastric cancer. | Oncogene | 2025 | 40188301 | PubTator, text mining | PubMed |
| Tumor-Derived Exosomal circ_0020095 Promotes Colon Cancer Cell Proliferation and Metastasis by Inhibiting M1 Macrophage Polarization. | J Biochem Mol Toxicol | 2025 | 40165503 | PubTator, text mining | PubMed |
| METTL3 regulated by histone lactylation promotes ossification of the ligamentum flavum by enhancing the m6A methylation of BMP2. | Mol Med | 2025 | 40133819 | PubTator, text mining | PubMed |
| Long noncoding RNA as an emerging regulator of endoderm differentiation: progress and perspectives. | Cell Regen | 2025 | 40133743 | PubTator, text mining | PubMed |
| ARRB2 promotes cervical cancer progression via stabilizing CDC25A mRNA through m6A-IGF2BP1-dependent manner. | NPJ Precis Oncol | 2025 | 40119070 | PubTator, text mining | PubMed |
| METTL3 promotes infantile pneumonia-induced lung injury by the m6A-TBL1XR1-ACSL1 axis. | Cell Immunol | 2025 | 40117788 | PubTator, text mining | PubMed |
| m6A-modified LINC02418 induces transcriptional and post-transcriptional modification of CTNNB1 via interacting with YBX1 and IGF2BP1 in colorectal cancer. | Cell Death Discov | 2025 | 40082414 | PubTator, text mining | PubMed |
| RBPsuite 2.0: an updated RNA-protein binding site prediction suite with high coverage on species and proteins based on deep learning. | BMC Biol | 2025 | 40069726 | PubTator, text mining | PubMed |
| Whole genome transcriptomic profiling reveals distinct sex-specific responses to heat stroke. | J Appl Physiol (1985) | 2025 | 40066897 | PubTator, text mining | PubMed |
LncRNA Growth Arrest Specific 5 Promotes Glucose Metabolism Reprogramming Via the IGF2BP1/SIX1 Axis and Inhibits Ferroptosis of Endothelial Progenitor Cells Via the miR-23a-3p/SLC7A11 Axis in Coronary Heart Disease. | Anatol J Cardiol | 2025 | 40062373 | PubTator, text mining | PubMed |
| IGF2BP1-HAX-1 positive feedback loop-mediated HAX-1 overexpression blocks autophagic flux and promotes chemoresistance in nasopharyngeal carcinoma. | Cell Mol Life Sci | 2025 | 40055185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10642/papers?page=12